Skip to main content

Table 1 Select de novo insertions in ASD and high pLI genes in affected individuals

From: Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder

Proband ID

TE Type

Gene

SFARI Classificationa

pLI

Genic Region

Validation Status

Observed Phenotype

Previous Neurodevelopmental Phenotype associated with gene

Reference

11,859.p1

Alu

CSDE1

No

1

Exon

Validated

ASD, language delay, ID, macrocephaly, history of vision correction, normal EEG at 4 years

LGD variants associated with ASD, developmental delay, ID, seizures, macrocephaly, ADHD, anxiety, ocular abnormalities

Guo et al. 2019 [22]

14,565.p1

Alu

KBTBD6

No

0.935

Exon

Validated

ASD, macrocephaly, uncoordinated, normal IQ, BMI Z-score − 3.91

  

12,548.p1

Alu

APPBP2

No

0.999

Intron

Validated

ASD, normal IQ, macrocephaly

  

12,748.p1

Alu

SYT1

Syndromic

0.837

Intron

Validated

ASD, normal IQ, uncoordinated

Developmental delays, autistic features, hypotonia, ocular abnormalities, hyperkinetic movements associated with de novo missense variation

Baker et al., 2018 [23]

13,931.p1

Alu

OTUD7A

Suggestive evidence

0.975

Intron

Validated

ASD, borderline IQ, normal EEG, and brain imaging

Neurodevelopmental phenotype of ASD, developmental delay, ID, seizures associated with 15q13.3 microdeletion syndrome

Yin et al. 2018 [24], Uddin et al. 2018 [25]

13,107.p1

Alu

TOX3

No

0.994

Intron

Validated

ASD, normal IQ

  

14,315.p1

Alu

JAZF1

No

0.958

Intron

Validated

ASD, borderline verbal IQ, normal nonverbal IQ, normal EEG

  

11,196.p1

L1

SRGAP3

Minimal Evidence

1

Intron

Validated

ASD, above average IQ, no history of seizures, heart problems reported

Case report of translocation breakpoint at loci posited to be LoF associated with hypotonia and severe ID

Endris et al. 2002 [26]

13,684.p1

L1

HCN1

Syndromic

0.953

Intron

NA

ASD, Tourette syndrome, above average IQ, GI problems, uncoordinated

Missense variation associated with a syndrome of seizures, intellectual disability, and autistic features, gene also implicated in Tourette syndrome, role in striatal neuronal function and enteric nervous system

Nava et al. 2014 [27], Tsetsos et al. [28] 2021

14,080.p1

L1

DAB1

Hypothesized

0.981

Intron

Validated

ASD, uncoordinated, GI problems

ASD, GI problems, schizophrenia, spinocerebellar ataxia-37 associated with non-coding nucleotide repeats

Corral-Juan et al. 2018 [29], Nawa et al. 2020 [30]

14,282.p1

L1

DPYD

Suggestive evidence

0

Intron

Not in LCL DNA, predicted blood mosaic

ASD, normal IQ

ASD, ID

Carter et al. 2011 [31], Willemsen et al. 2011 [32]

11,234.p1

L1

NOTCH2

No

1

Intron

NA

ASD, above average IQ

  

13,451.p1

L1

DPP10

Suggestive evidence

1

Intron

NA

ASD, borderline IQ

ASD

Marshall et al. 2008 [33]

14,404.p1

SVA

GRAMD1B

No

0.985

Intron

NA, predicted blood mosaic

ASD, non-verbal, IQ in profound intellectual disability range, macrocephaly

Autosomal recessive intellectual disability

Santos-Cortez et al. 2018 [34]

14,523.p1

SVA

ACACA

No

1

Intron

NA

ASD, above average IQ, macrocephaly

Acetyl-CoA carboxylase deficiency

Blom et al. 1981 [35]

  1. A subset of de novo TEIs observed in individuals with ASD in genes relevant to ASD or with a high probability of being loss-of-function intolerant (pLI > 0.9). aSFARI annotations were obtained in 2019. LCL Lymphoblastoid cell line, LGD Likely gene disrupting, ID Intellectual disability, LoF Loss of function, ADHD Attention-deficit hyperactivity disorder, GI Gastrointestinal.